Nestlé is buying the biotech firm that makes drugs against peanut allergy. The Swiss multinational conglomerate Nestlé shells out $2.6…
Nestlé is buying the biotech firm that makes drugs against peanut allergy. The Swiss multinational conglomerate Nestlé shells out $2.6…